Micrhogam Ultra-Filtered Plus
Need help?
Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.
What Is Micrhogam Ultra-Filtered Plus?
Micrhogam Ultra-Filtered Plus is a medication produced by KEDRION BIOPHARMA that falls under the category of immune serums. It is specifically used for Rh immunoglobulin therapy. This drug is used in certain medical situations to prevent complications in pregnant women who are Rh-negative and have been exposed to Rh-positive blood. When a pregnant woman is Rh-negative and comes into contact with Rh-positive blood, such as during pregnancy or childbirth, there is a risk of the mother's immune system producing antibodies that can attack the red blood cells of the developing fetus. This can lead to a condition known as Rh disease, which can cause severe health issues in the baby. Micrhogam Ultra-Filtered Plus contains Rh immunoglobulin, which works by suppressing the mother's immune response to Rh-positive blood. By doing so, it helps to prevent the formation of antibodies and reduce the risk of Rh disease in the baby. It's important to note that this medication should only be used under medical supervision and as prescribed by a healthcare provider. They will determine the appropriate dosage and administration schedule based on the specific needs of the patient. As with any medication, there may be potential side effects or contraindications, so it's important to discuss any concerns with a healthcare professional.
How to use Micrhogam Ultra-Filtered Plus?
Micrhogam Ultra-Filtered Plus is a medication that is typically used during pregnancy to prevent complications related to blood type incompatibility. It is often prescribed to Rh-negative women who are carrying an Rh-positive baby. The medication is administered as an injection and should be given by a healthcare professional. It is important to follow the instructions provided by your doctor or healthcare provider, as the dosage and timing may vary. Typically, Micrhogam Ultra-Filtered Plus is given within 72 hours after any event that could potentially cause the mixing of fetal and maternal blood, such as miscarriage, ectopic pregnancy, amniocentesis, or trauma during pregnancy. It may also be given around the time of delivery if the baby is Rh-positive. Since this medication is administered by a healthcare professional, they will determine the appropriate dosage and ensure that it is administered correctly. It is important to inform your healthcare provider of any allergies or medical conditions you may have before receiving Micrhogam Ultra-Filtered Plus. As always, make sure to consult with your healthcare provider for personalized and accurate information regarding the use of Micrhogam Ultra-Filtered Plus.
As with any medication, Micrhogam Ultra-Filtered Plus has certain warnings associated with its use. It is important to note that Micrhogam Ultra-Filtered Plus is an immune serum product used for individuals who have Rh-positive blood types and are at risk of developing Rh incompatibility during pregnancy or certain medical procedures. Here are some of the warnings related to Micrhogam Ultra-Filtered Plus: 1. Hypersensitivity Reactions: Some individuals may experience allergic or hypersensitivity reactions to the components of Micrhogam Ultra-Filtered Plus. It is essential to inform your healthcare provider of any known allergies or previous adverse reactions to help minimize the risk of these reactions. 2. Transmission of Infectious Agents: As Micrhogam Ultra-Filtered Plus is derived from human plasma, there is a potential risk of transmitting infectious agents, including viruses and variant Creutzfeldt-Jakob disease (vCJD) agents. Strict donor screening and testing are conducted to mitigate this risk, but it cannot be completely eliminated. The healthcare professional administering the medication should follow the appropriate guidelines to minimize transmission risks. 3. Hemolytic Reactions: In rare instances, administration of Micrhogam Ultra-Filtered Plus may cause hemolytic reactions, resulting in the destruction of red blood cells. This risk is higher for individuals with a known history of receiving immune serum products. Adequate patient monitoring should be carried out during and following administration to detect any signs of hemolysis. 4. Thrombocytopenia: Micrhogam Ultra-Filtered Plus may cause a decrease in blood platelet count (thrombocytopenia), leading to an increased risk of bleeding. Close monitoring of platelet levels is necessary during treatment. It is important to discuss these warnings with your healthcare provider before using Micrhogam Ultra-Filtered Plus. They will evaluate the potential risks and benefits and make an informed decision based on your specific medical situation.
Before taking Micrhogam Ultra-Filtered Plus, it is essential to be aware of the following warnings: 1. Allergic Reactions: If you have experienced an allergic reaction to human immune globulin or any other blood product in the past, it is crucial to inform your healthcare provider. Allergic reactions, although rare, can occur with the administration of Micrhogam Ultra-Filtered Plus. Signs of an allergic reaction may include hives, itching, difficulty breathing, and swelling of the face or throat. 2. Blood Clotting Disorders: Individuals with a history of blood clotting disorders or a family history of blood clotting problems should notify their healthcare provider. Micrhogam Ultra-Filtered Plus may increase the risk of blood clots, especially in individuals with these conditions. 3. Hemolytic Anemia: Micrhogam Ultra-Filtered Plus should not be administered to individuals with a known history of hemolytic anemia, a condition where red blood cells are destroyed too quickly. 4. Kidney Disease: If you have kidney disease or reduced kidney function, it is important to inform your healthcare provider. Dosage adjustments may be necessary to ensure the safe use of Micrhogam Ultra-Filtered Plus. 5. Blood Type Incompatibility: Micrhogam Ultra-Filtered Plus should only be given to individuals who have been tested and found to be Rh(D) negative, as it is specifically targeted for this blood type. Giving this medication to Rh(D) positive individuals may cause a severe adverse reaction. 6. Thrombocytopenia: People with a low platelet count (thrombocytopenia) should be cautious when using Micrhogam Ultra-Filtered Plus, as it may further decrease platelet levels. 7. Interactions with Other Medications: It is important to inform your healthcare provider about all the medications, supplements, and herbal products you are currently taking. Certain drugs may interact with Micrhogam Ultra-Filtered Plus, potentially altering its effectiveness or increasing the risk of side effects. Remember, this information is not exhaustive, and it is essential to consult with a healthcare professional for a comprehensive understanding of the warnings associated with Micrhogam Ultra-Filtered Plus.
Micrhogam Ultra-Filtered Plus is a medication classified as an immune serum, specifically an anti-D immune globulin. It is typically used to prevent complications from Rh incompatibility in pregnant women. Like any medication, Micrhogam Ultra-Filtered Plus can cause side effects in some individuals. Common side effects may include pain, swelling, or redness at the injection site. Headache, fatigue, and muscle pain are also possible. In rare cases, more serious side effects can occur. These may include allergic reactions with symptoms such as rash, itching, difficulty breathing, or swelling of the face, tongue, or throat. It's important to seek immediate medical attention if any of these symptoms arise. As with any medication, it is always recommended to discuss potential side effects with a healthcare professional before starting treatment. They can provide personalized information and guidance based on the individual's specific medical history and needs.
The main ingredient of Micrhogam Ultra-Filtered Plus is immune serum globulin (also known as human immunoglobulin or IgG). This medication is derived from human blood plasma and contains antibodies that can help prevent certain complications during pregnancy. Micrhogam Ultra-Filtered Plus is specifically used to prevent Rh sensitization, a condition where a pregnant woman's immune system produces antibodies that can harm the fetus. Rh sensitization can occur when a woman with Rh-negative blood is exposed to Rh-positive blood, typically during childbirth or pregnancy complications. The medication is processed using ultrafiltration techniques to remove potential impurities and unwanted components, making it safer for administration. It is important to consult with a healthcare professional for proper dosage and administration instructions, as well as to understand any potential side effects or risks associated with the use of Micrhogam Ultra-Filtered Plus.
Micrhogam Ultra-Filtered Plus should be stored appropriately to maintain its effectiveness and safety. Follow these storage guidelines for this medication: 1. Temperature: Store Micrhogam Ultra-Filtered Plus in a refrigerator between 2°C and 8°C (36°F and 46°F). 2. Protection from light: Keep the medication in its original carton to protect it from light. Do not expose it to direct sunlight or bright artificial light. 3. Do not freeze: Make sure the medication does not freeze. Freezing can degrade the product and affect its efficacy. 4. Avoid shaking: Do not shake the vial excessively, as this can denature the proteins in the medication. 5. Check expiration date: Always check the expiration date before using Micrhogam Ultra-Filtered Plus. Do not use if the medication has expired. It's important to follow the storage instructions provided by the manufacturer or your healthcare provider. If you have any doubts or concerns about storage, contact your pharmacist for clarification. Remember, proper storage helps maintain the quality and effectiveness of the medication.